PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32219734-4	2020	In the present study, we try to determine the neuroprotective capacity of KYNA on the QUIN effects in redox homeostasis changes (H2DCF oxidation, superoxide dismutase/catalase (SOD/CAT) ratio, glutathione peroxidase (GPx) activity, sulfhydryl content, and nitrite levels), as well as on inflammatory parameters (levels of TNF-alpha, IL-1beta, and IL-6).	Kynurenic Acid	74-78	interleukin 1 alpha	Rattus norvegicus	333-341	
32219734-7	2020	Results demonstrated that the KYNA administration was able to prevent the increase in reactive oxygen species, SOD/CAT ratio, and pro-inflammatory cytokines (IL-1beta and IL-6) and the decrease in GPx activity, sulfhydryl content, and nitrite levels caused by QUIN.	Kynurenic Acid	30-34	interleukin 1 alpha	Rattus norvegicus	158-166	
34475875-12	2021	Plasma levels of CitH3, MPO and IL-1beta were elevated in sepsis but were ameliorated by KYNA and its synthetic analogues.	Kynurenic Acid	89-93	interleukin 1 alpha	Rattus norvegicus	32-40